USPTO serial 99701154
ARBOR
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MOULTON, NICHOLAS C
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ARBOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen K. Won
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | engineered nucleic acid sequences for medical purposes; nucleases, fusion proteins, RNAs and biomolecular complexes for modification of cellular genome; gene editing agents for modifying RNA sequences; gene editing agents for modifying DNA sequences at genomic target sites; engineered biomolecular complexes comprised of fusion proteins and RNAs used for modifying nucleic acid sequences in human genomes; engineered biomolecular compound for enhanced regulation and correction of gene expression and mutations, excision and insertion of DNA sequences, and delivery of whole genes and nucleic acid sequences to target sites; gene therapy and cell therapy products in the nature of DNA editing complexes targeting genomic sites | ACTIVE | — |
| 040 | custom biomanufacturing of gene editing complexes; custom biomanufacturing of engineered fusion proteins and nucleic acids for use in Cell and Gene Therapy (CGT) | ACTIVE | — |
| 042 | bioengineering of proteins, nucleic acids, RNAs, and gene editing complexes used in genomic engineering; providing medical scientific research information in the fields of gene editing technologies and genomic engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Arbor Biotechnologies, Inc.
- Other trademarks owned by Arbor Biotechnologies, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ARBOR
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2026 | NWAP | NEW APPLICATION ENTERED | — |